These findings clearly demonstrate that sustained activation of NRF2 by p62 activation is responsible for HCC pathology, suggesting that NRF2 and KEAP1 mutations, as well as aberrant p62 activation enhance the growth of HCC cells through metabolic dysregulation. The gene discussed is KEAP1; the disease is hepatocellular carcinoma.